Home Other Building Blocks 10521-91-2
10521-91-2,MFCD00002979
Catalog No.:AA003MVN

10521-91-2 | 5-Phenylpentan-1-ol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
99%
in stock  
$42.00   $29.00
- +
5g
>98.0%(GC)
in stock  
$155.00   $108.00
- +
25g
>98.0%
in stock  
$577.00   $404.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003MVN
Chemical Name:
5-Phenylpentan-1-ol
CAS Number:
10521-91-2
Molecular Formula:
C11H16O
Molecular Weight:
164.2441
MDL Number:
MFCD00002979
SMILES:
OCCCCCc1ccccc1
NSC Number:
6590
FEMA Number:
3618
Properties
Properties
 
BP:
155°C at 760 mmHg  
Form:
Liquid  
Refractive Index:
n20/D 1.516(lit.)  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
95.2  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
5  
XLogP3:
2.8  

Downstream Synthesis Route

[1]Kamijo,Tetsuhide;Harada,Hiromu;Iizuka,Kinji[Chemicalandpharmaceuticalbulletin,1983,vol.31,#11,p.4189-4192]

[2]Furuta,Kyoji;Tomokiyo,Keiichiro;TienKuo;Ishikawa,Toshihisa;Suzuki,Masaaki[Tetrahedron,1999,vol.55,#24,p.7529-7540]

[3]Pouliot,Marie-France;Mahe,Olivier;Hamel,Jean-Denys;Desroches,Justine;Paquin,Jean-Francois[OrganicLetters,2012,vol.14,#21,p.5428-5431,4]

[4]Beauglehole;Baker;Scammells[JournalofMedicinalChemistry,2000,vol.43,#26,p.4973-4980]

[5]CurrentPatentAssignee:BAYERAG-US2009/227640,2009,A1Locationinpatent:Page/Pagecolumn39

[6]CurrentPatentAssignee:BAYERAG-US2009/286882,2009,A1Locationinpatent:Page/Pagecolumn17

[7]CurrentPatentAssignee:BAYERAG-US2010/29772,2010,A1Locationinpatent:Page/Pagecolumn14

[8]CurrentPatentAssignee:BAYERAG-US2010/168240,2010,A1Locationinpatent:Page/Pagecolumn12

[9]CurrentPatentAssignee:BAYERAG-US2009/215843,2009,A1Locationinpatent:Page/Pagecolumn17-18

[10]Mori,Mattia;Vignaroli,Giulia;Cau,Ylenia;Dinic̈,Jelena;Hill,Richard;Rossi,Matteo;Colecchia,David;Pešic̈,Milica;Link,Wolfgang;Chiariello,Mario;Ottmann,Christian;Botta,Maurizio[ChemMedChem,2014,vol.9,#5,p.973-983]

[11]Maercker,Adalbert;Passlack,Michael[ChemischeBerichte,1982,vol.115,#2,p.540-577]

[12]Kroon,JohannesM.;Koehorst,RobertB.M.;VanDijk,Marinus;Sanders,GeorgineM.;Sudhoelter,ErnstJ.R.[JournalofMaterialsChemistry,1997,vol.7,#4,p.615-624]

[13]Marcinek,Andrzej;Platz,MatthewS.;Chan,StephenY.;Floresca,Rey;Rajagopalan,Krishnan;etal.[JournalofPhysicalChemistry,1994,vol.98,#2,p.412-419]

[14]Hulshof,JannekeW.;Vischer,HenryF.;Verheij,MarkH.P.;Fratantoni,SilvinaA.;Smit,MartineJ.;deEsch,IwanJ.P.;Leurs,Rob[BioorganicandMedicinalChemistry,2006,vol.14,#21,p.7213-7230]

[15]VanderMey;Hatzelmann;VanKlink;VanderLaan;Sterk;Thibaut;Ulrich;Timmerman[JournalofMedicinalChemistry,2001,vol.44,#16,p.2523-2535]

[16]Truce;Wise[JournaloftheAmericanChemicalSociety,1950,vol.72,p.2300]

[17]Huisgenetal.[JustusLiebigsAnnalenderChemie,1954,vol.586,p.1,4][ChemischeBerichte,1957,vol.90,p.1946,1950]

[18]Truce;Milionis[JournaloftheAmericanChemicalSociety,1952,vol.74,p.974,975]Skinneretal.[JournalofOrganicChemistry,1956,vol.21,p.1330]

[19]Oae;VanderWerf[JournaloftheAmericanChemicalSociety,1953,vol.75,p.5037]

[20]Shklyaev,V.S.;Chekryshkin,Yu.S.[JournalofOrganicChemistryUSSR(EnglishTranslation),1968,vol.4,p.74-76][ZhurnalOrganicheskoiKhimii,1968,vol.4,p.79-8]v.Braun;Deutsch;Schmatloch[ChemischeBerichte,1912,vol.45,p.1255]

[21]Thomas,J.;Marlow,W.[JournalofMedicinalChemistry,1963,vol.6,p.107-111]Collins,R.F.;Davis,M.[JournaloftheChemicalSociety,1961,p.1863-1879]

[22]Lynch,E.R.;McCall,E.B.[JournaloftheChemicalSociety,1960,p.1254-1262]

[23]Wild,R.;Hesse,M.[HelveticaChimicaActa,1974,vol.57,p.452-464]Hubert,A.J.[JournaloftheChemicalSocietyC:Organic,1967,p.235-238]

[24]Gribble,AndrewD.;Dolle,RolandE.;Shaw,Antony;McNair,David;Novelli,Riccardo;Novelli,ChristineE.;Slingsby,BrianP.;Shah,VirendraP.;Tew,David;Saxty,BarbaraA.;Allen,Mark;Groot,PieterH.;Pearce,Nigel;Yates,John[JournalofMedicinalChemistry,1996,vol.39,#18,p.3569-3584]

[25]Torisawa;Nishi;Minamikawa[Bioorganicandmedicinalchemistryletters,2001,vol.11,#20,p.2787-2789]

[26]Torisawa,Yasuhiro;Nishi,Takao;Minamikawa,Jun-ichi[BioorganicandMedicinalChemistry,2002,vol.10,#8,p.2583-2587]

[27]CurrentPatentAssignee:AJINOMOTOCOMPANYINC-US5231105,1993,A

[28]CurrentPatentAssignee:ASTELLASPHARMAINC.-US4987132,1991,A

[29]Locationinpatent:bodytextMaslowska-Lipowicz,Iwona;Figlus,Marek;Zuiderveld,ObbeP.;Walczynski,Krzysztof[ArchivderPharmazie,2008,vol.341,#12,p.762-773]Locationinpatent:bodytextFrymarkiewicz,Anna;Walczynski,Krzysztof[EuropeanJournalofMedicinalChemistry,2009,vol.44,#4,p.1674-1681]

[30]CurrentPatentAssignee:VTVTHERAPEUTICSINC.-US2001/49385,2001,A1

[31]Guryn,Roman;Staszewski,Marek;Walczynski,Krzysztof[MedicinalChemistryResearch,2013,vol.22,#8,p.3640-3652]

[32]CurrentPatentAssignee:GOVERNMENTOFTHEUNITEDSTATES;ILLINOISINSTITUTEOFTECHNOLOGY-US9115094,2015,B2Locationinpatent:Page/Pagecolumn109;110;137-139

[33]Shiely,AmyE.;Clarke,Leslie-Ann;Flynn,ChristopherJ.;Buckley,AoifeM.;Ford,Alan;Lawrence,SimonE.;Maguire,AnitaR.[EuropeanJournalofOrganicChemistry,2018,vol.2018,#19,p.2277-2289]

[1]DeEsch;Gaffar;Menge;Timmerman[Bioorganicandmedicinalchemistry,1999,vol.7,#12,p.3003-3009]

[2]CurrentPatentAssignee:UNIVERSITYOFURBINO;ISTITUTOITALIANODITECNOLOGIA;UNIVERSITYOFCALIFORNIA;UNIVERSITYOFPARMA-WO2013/78430,2013,A1Locationinpatent:Paragraph0276

[3]CurrentPatentAssignee:UNIVERSITYOFURBINO;ISTITUTOITALIANODITECNOLOGIA;UNIVERSITYOFCALIFORNIA;UNIVERSITYOFPARMA-US9353075,2016,B2Locationinpatent:Page/Pagecolumn98

[4]Kelly,ChristopherB.;Ovian,JohnM.;Cywar,RobinM.;Gosselin,TaylorR.;Wiles,RebeccaJ.;Leadbeater,NicholasE.[OrganicandBiomolecularChemistry,2015,vol.13,#14,p.4255-4259]

[5]Kelly,ChristopherB.;Lambert,KyleM.;Mercadante,MichaelA.;Ovian,JohnM.;Bailey,WilliamF.;Leadbeater,NicholasE.[AngewandteChemie-InternationalEdition,2015,vol.54,#14,p.4241-4245]

[6]CurrentPatentAssignee:PFIZERINC-US5194446,1993,A

[7]Locationinpatent:experimentalpartTancini,Francesca;Gottschalk,Thomas;BerndSchweizer;Diederich,Francois;Dalcanale,Enrico[Chemistry-AEuropeanJournal,2010,vol.16,#26,p.7813-7819]

[8]Jaita,Subin;Kaewkum,Pantitra;Duangkamol,Chuthamat;Phakhodee,Wong;Pattarawarapan,Mookda[RSCAdvances,2014,vol.4,#87,p.46947-46950]

[9]Barclay,L.R.C.etal.[CanadianJournalofChemistry,1964,vol.42,p.579-590]Julia,M.;Chottard,J.-C.[BulletindelaSocieteChimiquedeFrance,1968,p.3691-3700]

[10]Lynch,E.R.;McCall,E.B.[JournaloftheChemicalSociety,1960,p.1254-1262]

[11]Shing,Ka-Pan;Liu,Yungen;Cao,Bei;Chang,Xiao-Yong;You,Tingjie;Che,Chi-Ming[AngewandteChemie-InternationalEdition,2018,vol.57,#37,p.11947-11951][Angew.Chem.,2018,vol.130,p.12123-12127,5]

[12]Nouaille,Augustin;Pannecoucke,Xavier;Poisson,Thomas;Couve-Bonnaire,Samuel[AdvancedSynthesisandCatalysis,2021,vol.363,#8,p.2140-2147]

[13]Fan,Zhoulong;Lam,NelsonY.S.;Park,HanSeul;Shim,SuYong;Strassfeld,DanielA.;Wu,Kevin;Yu,Jin-Quan[JournaloftheAmericanChemicalSociety,2022,vol.144,#6,p.2793-2803]

[1]Duplantier,AllenJ.;Biggers,MichaelS.;Chambers,RobertJ.;Cheng,JohnB.;Cooper,Kelvin;Damon,DavidB.;Eggler,JamesF.;Kraus,KennethG.;Marfat,Anthony;Masamune,Hiroko;Pillar,JoannS.;Shirley,JohnT.;Umland,JohnP.;Watson,JohnW.[JournalofMedicinalChemistry,1996,vol.39,#1,p.120-125]

10521-91-2    3150-24-1   
5-Phenylpentylβ-D-galactopyranoside 

[1]Mori,Toshiaki;Okahata,Yoshio[ChemicalCommunications,1998,#20,p.2215-2216]

[2]Mori,Toshiaki;Okahata,Yoshio[TetrahedronLetters,1997,vol.38,#11,p.1971-1974]

[3]Okahata,Yoshio;Mori,Toshiaki[JournaloftheChemicalSociety.PerkintransactionsI,1996,#23,p.2861-2866]

[4]Mori,Toshiaki;Li,Ming;Kobayashi,Atsushi;Okahata,Yoshio[JournaloftheAmericanChemicalSociety,2002,vol.124,#7,p.1188-1189]

10521-91-2    3459-18-5   
N-(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-hydroxymethyl-2-(5-phenyl-pentyloxy)-tetrahydro-pyran-3-yl-acetamide 

[1]Mori,Toshiaki;Okahata,Yoshio[TetrahedronLetters,1997,vol.38,#11,p.1971-1974]

Literature

Title: Methoxy- and fluorine-substituted analogs of O-1302: synthesis and in vitro binding affinity for the CB1 cannabinoid receptor.

Journal: Chemical & pharmaceutical bulletin 20070801

Title: Enhancing effect of alpha-hydroxyacids on 'in vitro' permeation across the human skin of compounds with different lipophilicity.

Journal: International journal of pharmaceutics 20060511

Title: Preparation and properties of gelatin-immobilized beta-glucosidase from Pyrococcus furiosus.

Journal: Bioscience, biotechnology, and biochemistry 20050101

Title: Simple synthesis of beta-D-glycopyranosides using beta-glycosidase from almonds.

Journal: Chemical & pharmaceutical bulletin 20040201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:10521-91-2 Molecular Formula|10521-91-2 MDL|10521-91-2 SMILES|10521-91-2 5-Phenylpentan-1-ol